Belgium (BE)

Lost in Regulation: Nord Stream 2 and the Limits of the European Commission’s Geo-Economic Power (2021) de Jong M, Van de Graaf T Journal article The EHA research Roadmap: Immune-based therapies for hematological malignancies (2021) Einsele H, Briones J, Ciceri F, Garcia Cadenas I, Falkenburg F, Bolanos N, Heemskerk HMM, et al. Journal article, Review article Outcome Prognostication of Acute Brain Injury using the Neurological Pupil Index (ORANGE) study: protocol for a prospective, observational, multicentre, international cohort study. (2021) Oddo M, Taccone F, Galimberti S, Rebora P, Citerio G Journal article Sensitive optomechanical ultrasound sensor in a silicon photonic chip towards single-shot photoacoustic imaging with an ultrasound sensor matrix (2021) Pieters C, Westerveld WJ, Mahmud-Ul-Hasan M, Severi S, Shnaiderman R, Ntziachristos V, Billen M, et al. Conference contribution Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study (2021) Dommasch M, Steger A, Barthel P, Huster KM, Mueller A, Sinnecker D, Laugwitz KL, et al. Journal article Deciphering the Role of Heme Oxygenase-1 (HO-1) Expressing Macrophages in Renal Ischemia-Reperfusion Injury. (2021) Rossi M, Korpak K, Doerfler A, Zouaoui Boudjeltia K Journal article, Review article Corrigendum to: More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis. (2021) Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, Cooper KW, et al. Journal article, Erratum Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. (2021) Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. (2021) Eggermont AM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, et al. Journal article Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies. (2021) Mcgonagle D, Mcinnes IB, Deodhar A, Schett G, Shawi M, Kafka S, Karyekar CS, et al. Journal article